SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-19-005919
Filing Date
2019-06-27
Accepted
2019-06-27 06:35:42
Documents
3
Period of Report
2019-06-26
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 46154
2 EX-99.1 ex-99d1.htm EX-99.1 34877
3 GRAPHIC ex-99d1g001.jpg GRAPHIC 158550
  Complete submission text file 0001558370-19-005919.txt   300383
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 19922916
SIC: 2834 Pharmaceutical Preparations